BABY-PULSARNCT07918105
A Phase-1 Trial to Investigate the Use of Pulsed Low-dose Rate Radiotherapy in Diffuse Midline Gliomas.
StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Determination of the safe dose level of pulsed low-dose-rate radiotherapy (pLDRT)
Timeframe: Up to 5 years
Secondary (8)
To evaluate the median time to local disease progression.
To evaluate median overall survival.
To assess the incidence of treatment-related toxicities other than dose-limiting toxicities.
To assess changes in neurological symptoms compared with baseline.
To evaluate corticosteroid use during radiotherapy.
Show 3 moreShow less
To evaluate circulating prognostic and predictive biomarkers of response to pLDRT.
To evaluate tissue biomarkers of response to pLDRT.
To characterize the inflammatory and immune profile induced by the pLDRT treatment schedule.
Arms and interventions
Determination of the safe dose level of pulsed low-dose-rate radiotherapy (pLDRT)Experimental
Radiation: Pulsed Low-Dose-Rate Radiotherapy, pLDRT
Sites
1 site in 1 country
- Centro di Riferimento Oncolgico -IRCCSAviano, Pordenone, Italy